Probity Advisors, Inc. Biogen Inc. Transaction History

Probity Advisors, Inc.

$515 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $178,707 - $222,043	938 New	938 $217,000
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $9,083 - $10,495	-33 Reduced 4.45%	708 $201,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $5,553 - $6,747	-22 Reduced 2.88%	741 $205,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $148,548 - $204,834	763 New	763 $204,000
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $185,631 - $233,886	-958 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $96,061 - $123,453	-429 Reduced 30.93%	958 $230,000
Q3 2021 Oct 08, 2021	BUY	$282.99 - $369.05 $2,829 - $3,690	10 Added 0.73%	1,387 $393,000
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $12,950 - $20,735	50 Added 3.77%	1,377 $477,000
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $24,537 - $28,747	101 Added 8.24%	1,327 $371,000
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $5,295 - $6,114	-20 Reduced 1.61%	1,226 $348,000
Q2 2020 Aug 03, 2020	SELL	$258.66 - $342.55 $329,015 - $435,723	-1,272 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $11,829 - $15,005	-44 Reduced 3.34%	1,272 $402,000
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $20,245 - $27,974	-92 Reduced 6.53%	1,316 $390,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $35,442 - $39,752	163 Added 13.09%	1,408 $328,000
Q2 2019 Aug 08, 2019	BUY	$219.29 - $241.72 $30,262 - $33,357	138 Added 12.47%	1,245 $291,000
Q1 2019 Apr 29, 2019	BUY	$216.71 - $338.96 $8,451 - $13,219	39 Added 3.65%	1,107 $262,000
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $7,241 - $9,171	-26 Reduced 2.38%	1,068 $321,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $5,870 - $7,676	20 Added 1.86%	1,094 $387,000
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $16,223 - $19,335	63 Added 6.23%	1,074 $312,000
Q1 2018 Apr 16, 2018	BUY	$260.13 - $367.91 $34,597 - $48,932	133 Added 15.15%	1,011 $277,000
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $22,457 - $25,154	73 Added 9.07%	878 $280,000
Q3 2017 Oct 27, 2017	BUY	$281.15 - $329.69 $226,325 - $265,400	805	805 $252,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.

Account